Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jolanda Donatella Vincelli"'
Autor:
Sabina Russo, Paolo Sportoletti, Massimo Breccia, Jolanda Donatella Vincelli, Ambra Di Veroli, Mario Tiribelli, Rikard Mullai, Giuseppina Loglisci, Pamela Murgano, Anna Rita Scortechini, Debora Luzi, Monica Bocchia, Sabrina Leonetti Crescenzi, Cristina Bucelli, Fabio Stagno, Alessandro Maggi, Federica Sorà, Mario Annunziata, Massimiliano Bonifacio, Elisabetta Abruzzese, Alessandra Malato, Isabella Capodanno, Annapaola Leporace, Giovanni Caocci, Roberto Latagliata, Giuseppe Saglio, Imma Attolico, Francesco Cavazzini, Luigiana Luciano, Giorgina Specchia, Elena Crisà, Gianni Binotto, Rosaria Sancetta, Chiara Elena, Carmen Fava, Alessandra Iurlo, Maria Cristina Miggiano, Gioia Colafigli, Monica Crugnola, Davide Rapezzi
Publikováno v:
Blood. 138:3617-3617
Introduction Treatment of chronic phase (CP) chronic myeloid leukemia (CML) with tyrosine kinase inhibitors (TKIs) proved to be almost equally effective in young and elderly patients. Three TKIs, imatinib (IM), dasatinib (DAS) and nilotinib (NIL), ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a656c5db7bbc6ea97ffa4508a73baa0e
https://doi.org/10.1182/blood-2021-151538
https://doi.org/10.1182/blood-2021-151538
Autor:
Massimo Martino, Angela Violi, Stefania Ciolli, Corrado Mammì, Bruno Martino, Irene Bova, Antonio Scopelliti, Jolanda Donatella Vincelli, Maria Grazia D'Errigo, B Oliva, Cristina Garreffa
Publikováno v:
Blood. 138:4735-4735
Until recently, MM was defined using strict clinical pathological criteria that required evidence of specific end-organ damage (CRAB) attributable to the underlying clonal plasma cell disorder. In the case of absence of end-organ damage, patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::df8c09de127e5554ff2cb7af27df826e
https://doi.org/10.1182/blood-2021-150620
https://doi.org/10.1182/blood-2021-150620